Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sintilimab in combination with Xelox as neoadjuvant therapy for resectable locally advanced gastric or gastroesophageal aden…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Sintilimab (sintilimab)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN